Carl read theCarl’s one-liner: Overall fat loss, aimed squarely at the gut.
The combo
RetatrutideTriple-G agonist — total fat lossRead guide →
TesamorelinGHRH — targets visceral belly fat + GHRead guide →
Why run them together
Retatrutide drives overall weight loss; Tesamorelin adds two things it doesn’t: trial-backed reduction of visceral (deep abdominal) fat, and GH/IGF-1 support that helps preserve lean muscle during the deficit.
It’s the ‘lose fat everywhere, but especially the belly, and hold onto muscle’ stack.
Running it together
Community-reported dosing & timing for the pair (Reddit & forums) — logged for education, not a recommendation to use:
| Component | Community protocol |
|---|---|
| Retatrutide | 1–2 mg/week to start, titrate to 4–12 mg |
| Tesamorelin | 1–2 mg nightly, subQ, fasted before bed |
| Cycle | Tesamorelin runs multi-month (VAT effects build over 12+ weeks) |
| Timing | Reta weekly; Tesa nightly; titrate Reta slowly |
The synergy
- Reta = total fat loss; Tesa = visceral-fat targeting + GH.
- GH support helps spare muscle during an aggressive cut.
- Two mechanisms aimed at the hardest fat to shift.
Cautions: Retatrutide is unapproved (phase-3, glucagon can raise heart rate); Tesamorelin is approved only for a narrow indication and carries GH cautions (water retention, glucose, joint symptoms). A demanding, supervision-heavy stack — bloodwork and a clinician strongly advised.
Who it’s for
Stubborn visceral fat, in experienced and closely-monitored users. As always: read each compound’s full guide, and talk to a clinician before running anything.
